Newcastle upon Tyne, United Kingdom

Emily Crozier



 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emily Crozier - Innovator in Bio-Macromolecule Separation

Introduction

Emily Crozier, an accomplished inventor based in Newcastle upon Tyne, Great Britain, is making significant contributions in the field of bio-macromolecule separation. With her innovative thinking and expertise, she has secured a patent that addresses complex challenges in DNA extraction.

Latest Patents

Emily holds a patent for a novel sorbent material specifically designed for the one-step separation of bio-macromolecules. This invention simplifies the extraction of DNA from intricate mixtures of molecules and chemicals, making processes more efficient. The invention features a sorbent material that includes a silanized component coated or formed with specific polymers, such as poly(aryl methacrylate) and poly(heteroaryl acrylate), enhancing its utility in molecular biology applications.

Career Highlights

Emily is associated with QuantumDX Group Limited, a company dedicated to innovating healthcare technologies. Her work at QuantumDX showcases her commitment to leveraging science and technology to improve vital processes in molecular diagnostics. With one patent to her name, she exemplifies the potential of innovative thinking combined with practical application.

Collaborations

Throughout her career, Emily has collaborated with talented individuals such as Jonathan James O'Halloran and Joseph H Hedley. These partnerships not only highlight a team-focused approach but also contribute to the advancement of individual and collective innovations within the research community.

Conclusion

Emily Crozier represents the spirit of innovation in the realm of bio-macromolecule separation. Her patented technology holds immense potential to streamline biological procedures, particularly in the field of DNA extraction. As she continues her work at QuantumDX Group Limited, Emily will undoubtedly pave the way for future advancements in biotechnology and molecular diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…